Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response
Description
Understanding the molecular features of neutralizing epitopes is important for developing vaccines/therapeutics against emerging SARS-CoV-2 variants. We describe three monoclonal antibodies (mAbs) generated from COVID-19 recovered individuals during
